Abstract
We compared two models of acute otitis media that estimate middle ear antimicrobial pharmacokinetics. Using a crossover study design, we compared a systemic drug administration model with a diffusion model we devised that measures the disappearance of antimicrobials from the middle ear. We induced acute otitis media in 14 chinchillas by inoculating S. pneumoniae into the middle ear, then administered 3 antimicrobials: amoxicillin, trimethoprim, and sulfamethoxazole. Next we collected middle ear fluid samples to analyze drug concentrations and compare rate constants for the systemic and diffusion models by analysis of variance. We found that amoxicillin K values were not affected by model testing sequence (p = 0.827) or model type (systemic versus diffusion, p = 0.310), nor were sulfamethoxazole K values: model testing sequence (p = 0.917), model type (p = 0.963). Trimethoprim K values were also not affected by model testing sequence (p = 0/760), but were by model type (p = 0.0001). Trimethoprim elimination from the diffusion model was faster (K = 0.33 ± 0.17 versus 0.57 ± 0.09 hr−1) than from the systemic model, although it appears this was caused by sampling before drug distribution into the middle ear was complete. In conclusion, it appears K values derived from either systemic antimicrobial administration or direct middle ear instillation are similar for assessing middle ear anitmicrobial pharmacokinetics, and these models can be used interchangeably to study factors affecting otitis media treatment response.
Similar content being viewed by others
References
G. S. Giebink, D. M. Canafax, J. Kempthorne. Antimicrobial treatment of acute otitis media. J. Pediatr. 119 (3):495–500 (1991).
D. M. Canafax, G. S. Giebink. Clinical and pharmacokinetic basis for the antimicrobial treatment of acute otitis media. Otolaryngol Clin of N Amer. 24 (4):859–876 (1991).
D. M. Canafax, N. Nonomura, G. R. Erdmann, C. T. Le, S. K. Juhn, G. S. Giebink. Experimental animal models for studying antimicrobial pharmacokinetics in otitis media. Pharmaceutical Research. 6:279–285 (1989).
G. H. Jossart, G. R. Erdmann, D. G. Levitt, P. Kucera, C. T. Le, S. K. Juhn, G. S. Giebink, D. M. Canafax. An experimental model for measuring middle ear antimicrobial drug penetration in otitis media. Pharmaceutical Research. 7 (12):1242–1247 (1990).
G. R. Erdmann, C. Walker, G. S. Giebink, D. M. Canafax. The analysis of amoxicillin concentrations by high-performance liquid chromatography in experimental middle ear effusion. J. Liq. Chromatogr. 13 (16):3339–3350 (1990).
G. R. Erdmann, D. M. Canafax, G. S. Giebink. High-performance liquid chromatographic analysis of trimethoprim and sulfamethoxazole in microliter volumes of chinchilla middle ear effusion and serum. J Chromatogr. 433:187–195 (1988).
K. K. Chan, K. Wnuck. Microcomputer based pharmacokinetic programs for calculating absorption rate. Comp Programs in Biomed. 16:27–34 (1983).
G. S. Giebink, W. L. Meyerhoff, and E. I. Cantekin. In Experimental Models in Antimicrobial Chemotherapy, Vol. 1, Academic Press, London, 1986, pp. 213–36.
K. Vance-Bryan, T. A. Larson, M. W. Garrison, J. P. Toscano, D. M. Canafax, J. C. Rotschafer. An in vitro pharmacodynamic model to simulate acute otitis media with effusion. Pharmaceutical Research. 9 (7):920–924 (1992).
G. H. Jossart, D. M. Canafax, G. R. Erdmann, M. J. Lovdahl, H. Q. Russlie, S. K. Juhn, G. S. Giebink. Effect of Streptococcus pneumoniae and influenza A virus on middle ear antimicrobial pharmacokinetics in experimental otitis media. Pharmaceutical Research 11 (6):860–864 (2994).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Canafax, D.M., Russlie, H., Lovdahl, M.J. et al. Comparison of Two Otitis Media Models for the Study of Middle Ear Antimicrobial Pharmacokinetics. Pharm Res 11, 855–859 (1994). https://doi.org/10.1023/A:1018981808868
Issue Date:
DOI: https://doi.org/10.1023/A:1018981808868